PTK2 and pancreatic neoplasm: Inhibition of FAK decreased PDAC cell growth and migration in vitro191, 192, and limited pancreatic tumour progression in vivo, doubling the survival in the p48‐Cre;LSL‐KrasG12D;Trp53flox/+ (KPC) mouse model of PDAC 25, 193, 194.